S
S

Spotify

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Fintech Wise to pioneer direct listing in boost to London

By Pamela Barbaglia, Abhinav Ramnarayan and Anna Irrera LONDON, June 17 (Reuters) - Wise, the British financial technology firm previously known as TransferWise, said on Thursday it plans to go public with the first direct listing on London's main market. The London-based payments app founded in 2010 by two Estonian entrepreneurs, said it is opting
B
C
G
S

Tencent Music says facing increased China scrutiny, is committed to laws

(Recasts with executive's comments on Chinese regulatory probe) May 18 (Reuters) - Tencent Music Entertainment Group TME.N confirmed on Tuesday it is facing heightened scrutiny from Chinese regulators, adding it was "actively co-operating" with them and is committed to complying with all laws "including those related to anti-trust". This is the fir
S

EU hits Apple with music streaming charge in boost for Spotify

* EU says Apple distorts competition in music streaming * Preliminary finding is a victory for Spotify * Apple says EU view is 'opposite of fair competition' By Foo Yun Chee BRUSSELS, April 30 (Reuters) - EU regulators accused Apple AAPL.O on Friday of distorting competition in the music streaming market, siding with Spotify SPOT.N in a case that c
A
S

EU antitrust regulators charge Apple over App Store restrictions

BRUSSELS, April 30 (Reuters) - EU antitrust regulators on Friday charged iPhone maker Apple AAPL.O with setting restrictive rules on its App Store that force developers to use its own in-app payment system and prevent them from informing users of other purchasing options. The move by the European Commission followed a complaint by Swedish music str
A
S

UK Stocks-Factors to watch on April 26

April 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 9 points lower on Monday, according to financial bookmakers. * ASTRAZENECA: Canada's health department said on Sunday the 1.5 million doses of the AstraZeneca Plc AZN.L COVID-19 vaccine imported from Emergent BioSolutions EBS.N Baltimore facility were safe and met quality specifica
A
I
P
R
U
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.